Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
ObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health syste...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/full |
_version_ | 1811309352310538240 |
---|---|
author | Jonathan G. Leung Prasanna P. Narayanan Matej Markota Nathaniel E. Miller Kemuel L. Philbrick M. Caroline Burton Robert W. Kirchoff |
author_facet | Jonathan G. Leung Prasanna P. Narayanan Matej Markota Nathaniel E. Miller Kemuel L. Philbrick M. Caroline Burton Robert W. Kirchoff |
author_sort | Jonathan G. Leung |
collection | DOAJ |
description | ObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health system with sites in Arizona, Florida, and Minnesota.ResultsResponses were obtained and included for 146/770 prescribers (19.0% response rate). Most respondents were in the department of internal medicine (n = 94, 64.4%), but the departments of psychiatry (n = 22, 15.1%) and family medicine (n = 30, 20.5%) were also represented. Only 34 (23.3%) respondents indicated they had prescribed naltrexone in the previous 3 months. The most common reasons for not prescribing naltrexone were “unfamiliarity with naltrexone for treatment of alcohol use disorder” and “patients do not have appropriate follow-up or are not in a formal treatment program.” Compared with those representing internal/family medicine, psychiatry respondents were more likely to prescribe naltrexone and answer knowledge questions correctly.ConclusionIn this survey among primarily non-addiction-trained prescribers, a disparity was shown for prescribing naltrexone and in knowledge barriers between staff in internal/family medicine and psychiatry. There exist opportunities for education and quality improvement that promote the prescribing of naltrexone for alcohol use disorder by non-addiction specialists. |
first_indexed | 2024-04-13T09:40:44Z |
format | Article |
id | doaj.art-2b742d5323e446baa5f40ad6c033bf77 |
institution | Directory Open Access Journal |
issn | 1664-0640 |
language | English |
last_indexed | 2024-04-13T09:40:44Z |
publishDate | 2022-05-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Psychiatry |
spelling | doaj.art-2b742d5323e446baa5f40ad6c033bf772022-12-22T02:51:56ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402022-05-011310.3389/fpsyt.2022.856938856938Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite SurveyJonathan G. Leung0Prasanna P. Narayanan1Matej Markota2Nathaniel E. Miller3Kemuel L. Philbrick4M. Caroline Burton5Robert W. Kirchoff6Pharmacy Services, Mayo Clinic, Rochester, MN, United StatesPharmacy Services, Mayo Clinic, Rochester, MN, United StatesDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United StatesMayo Family Clinic Kasson, Kasson, MN, United StatesDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, United StatesDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, United StatesDivision of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, United StatesObjectiveTo survey barriers in prescribing naltrexone for alcohol use disorder.MethodsA 12-question survey related to naltrexone prescribing patterns, perceptions, and knowledge was sent to 770 prescribers in the departments of internal medicine, family medicine, and psychiatry across a health system with sites in Arizona, Florida, and Minnesota.ResultsResponses were obtained and included for 146/770 prescribers (19.0% response rate). Most respondents were in the department of internal medicine (n = 94, 64.4%), but the departments of psychiatry (n = 22, 15.1%) and family medicine (n = 30, 20.5%) were also represented. Only 34 (23.3%) respondents indicated they had prescribed naltrexone in the previous 3 months. The most common reasons for not prescribing naltrexone were “unfamiliarity with naltrexone for treatment of alcohol use disorder” and “patients do not have appropriate follow-up or are not in a formal treatment program.” Compared with those representing internal/family medicine, psychiatry respondents were more likely to prescribe naltrexone and answer knowledge questions correctly.ConclusionIn this survey among primarily non-addiction-trained prescribers, a disparity was shown for prescribing naltrexone and in knowledge barriers between staff in internal/family medicine and psychiatry. There exist opportunities for education and quality improvement that promote the prescribing of naltrexone for alcohol use disorder by non-addiction specialists.https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/fullalcohol use disordernaltrexoneprescribingsubstance use disordersurvey |
spellingShingle | Jonathan G. Leung Prasanna P. Narayanan Matej Markota Nathaniel E. Miller Kemuel L. Philbrick M. Caroline Burton Robert W. Kirchoff Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey Frontiers in Psychiatry alcohol use disorder naltrexone prescribing substance use disorder survey |
title | Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey |
title_full | Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey |
title_fullStr | Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey |
title_full_unstemmed | Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey |
title_short | Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey |
title_sort | assessing naltrexone prescribing and barriers to initiation for alcohol use disorder a multidisciplinary multisite survey |
topic | alcohol use disorder naltrexone prescribing substance use disorder survey |
url | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.856938/full |
work_keys_str_mv | AT jonathangleung assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT prasannapnarayanan assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT matejmarkota assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT nathanielemiller assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT kemuellphilbrick assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT mcarolineburton assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey AT robertwkirchoff assessingnaltrexoneprescribingandbarrierstoinitiationforalcoholusedisorderamultidisciplinarymultisitesurvey |